CINECA IRIS Institutional Research Information System

SOFFIETTI, Riccardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.213
EU - Europa 6.808
AS - Asia 4.768
SA - Sud America 359
OC - Oceania 154
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 16
Totale 21.388
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.869
CN - Cina 2.240
IT - Italia 1.525
IE - Irlanda 989
DE - Germania 684
SG - Singapore 623
FR - Francia 595
JP - Giappone 584
SE - Svezia 552
UA - Ucraina 519
GB - Regno Unito 383
FI - Finlandia 373
KR - Corea 371
ES - Italia 313
CA - Canada 263
VN - Vietnam 207
PL - Polonia 199
BR - Brasile 181
IN - India 167
AU - Australia 147
NL - Olanda 127
TW - Taiwan 90
CO - Colombia 81
TR - Turchia 81
HK - Hong Kong 78
CH - Svizzera 77
ID - Indonesia 77
AT - Austria 76
BE - Belgio 74
MX - Messico 73
TH - Thailandia 66
RU - Federazione Russa 65
IL - Israele 61
NO - Norvegia 44
RO - Romania 41
GR - Grecia 33
AR - Argentina 31
PT - Portogallo 31
PE - Perù 27
IR - Iran 23
MY - Malesia 23
CL - Cile 22
DK - Danimarca 22
CZ - Repubblica Ceca 19
SA - Arabia Saudita 19
SI - Slovenia 15
PK - Pakistan 14
SN - Senegal 12
EU - Europa 11
GH - Ghana 10
NG - Nigeria 10
JO - Giordania 8
UY - Uruguay 8
EG - Egitto 7
HU - Ungheria 7
NZ - Nuova Zelanda 7
RS - Serbia 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
BG - Bulgaria 6
KE - Kenya 6
LT - Lituania 6
MA - Marocco 6
PH - Filippine 6
BA - Bosnia-Erzegovina 5
LB - Libano 5
SK - Slovacchia (Repubblica Slovacca) 5
HR - Croazia 4
LU - Lussemburgo 4
MU - Mauritius 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AP - ???statistics.table.value.countryCode.AP??? 3
DZ - Algeria 3
EC - Ecuador 3
IQ - Iraq 3
SM - San Marino 3
AM - Armenia 2
CI - Costa d'Avorio 2
CU - Cuba 2
CY - Cipro 2
GT - Guatemala 2
IS - Islanda 2
KW - Kuwait 2
MO - Macao, regione amministrativa speciale della Cina 2
MV - Maldive 2
PA - Panama 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
PR - Porto Rico 1
Totale 21.388
Salva come PNG Salva come JPEG
Città #
Beijing 1.013
Dublin 972
Chandler 864
Fairfield 549
Houston 498
Singapore 460
Ashburn 365
Medford 358
Torino 341
Villeurbanne 339
Wilmington 336
Princeton 315
Woodbridge 297
Jacksonville 262
Ann Arbor 253
Redwood City 246
Seattle 211
Nyköping 207
Hangzhou 204
Cambridge 202
Tokyo 178
Warsaw 172
Pisa 138
Dong Ket 137
Shanghai 133
Dearborn 124
Milan 120
Boston 98
Guangzhou 96
Madrid 91
Toronto 87
Santa Clara 82
New York 76
Turin 71
Fremont 70
Boardman 63
Nanjing 62
Jakarta 61
Seoul 60
Norwalk 56
Chengdu 55
Taipei 55
Rome 52
Vienna 51
San Diego 48
Bogotá 43
Munich 38
Verona 37
Wuhan 35
London 34
Jinan 33
Philadelphia 32
Sydney 32
Zhengzhou 31
Barcelona 30
Berlin 30
Helsinki 29
Ottawa 28
Falls Church 27
Bangkok 26
Istanbul 26
Lachine 26
Shenyang 26
Lexington 24
Lima 24
Brussels 23
Hefei 23
Central District 22
Los Angeles 22
Rochester 22
Chongqing 21
Kunming 21
Mountain View 20
Phoenix 20
Tel Aviv 20
Utrecht 20
Zurich 20
Fuzhou 19
Melbourne 19
Paris 19
Chicago 18
Osaka 18
Washington 18
Amsterdam 17
Oslo 17
Winnipeg 17
Des Moines 15
Duncan 15
Hanoi 15
Indianapolis 15
Montréal 15
Santiago 15
Tianjin 15
Buenos Aires 14
Buffalo 14
Changsha 14
Frankfurt am Main 14
Hebei 14
Medellín 14
Redmond 14
Totale 11.758
Salva come PNG Salva come JPEG
Nome #
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial 3.047
STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis article 1.152
A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. 1.052
Epilepsy and brain tumors. 547
Targeted therapy in brain metastasis 403
MGMT promoter methylation in plasma of glioma patients receiving temozolomide. 339
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas 335
Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016 291
Anti-Angiogenic Approaches to Malignant Gliomas 211
Updates in the management of brain metastases 194
La palliazione in radioterapia oncologica 180
The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors 178
Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas 175
A prognostic gene expression signature in infratentorial ependymoma. 170
Mechanisms and therapy for cancer metastasis to the brain 164
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma 163
Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas 160
Skin metastases of glioblastoma in the absence of intracranial progression are associated with a shift towards a mesenchymal immunophenotype: report of two cases 158
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningioma 150
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients 149
Does valproic acid affect tumor growth and improve survival in glioblastomas? 147
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer 144
Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma 132
Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial 130
Tumori cerebrali 125
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study. 124
NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target 119
Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. 118
Neoplasie del sistema nervoso centrale 115
The Evolving Landscape of Brain Metastasis 115
Primitive cerebral melanoma: case report and review of the literature. 111
Radio- and chemotherapy of malignant gliomas. Pathological changes in the normal nervous tissue. 108
Tissue alterations induced by radio- and chemotherapy in brain with malignant gliomas. 108
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis 108
Bevacizumab and fotemustine for recurrent glioblastoma: a phase II study of AINO (Italian Association of Neuro-Oncology) 103
Successful use of bevacizumab in an adult primary diffuse leptomeningeal glioneuronal tumor 103
Liquid biopsy in Central Nervous System metastases: a RANO review and proposals for clinical applications 103
Automatic segmentation and therapy follow-up of cerebral glioma in diffusion-tensor images 102
Point/Counterpoint: Is stereotactic radiosurgery needed following resection of brain metastasis? 99
Gliomi: monitoraggio dello stato di metilazione del gene MGMT nel DNA plasmatico dei pazienti sottoposti a chemioterapia con agenti alchilanti 98
Efficacy of radiation therapy for epileptic seizures of grade 2 and 3 gliomas: a retrospective study 97
The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma 93
A pathologic study of malignant gliomas operated after radio- and chemotherapy. 92
A comprehensive characterization of mitochondrial DNA mutations in glioblastoma multiforme 91
EANO guidelines for the diagnosis and treatment of ependymal tumors. 90
Prognostic characterization of higher-grade meningiomas: A histopathological score to predict progression and outcome 89
Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring 88
Pathology of human malignant gliomas after radiation and chemotherapy. 87
Association between multiple sclerosis and oligodendroglioma. Case report. 86
Molecularly based management of gliomas in clinical practice 85
Controversies in management of low-grade gliomas in light of new data from clinical trials. 85
Delayed adverse effects after irradiation of gliomas: clinicopathological analysis. 82
Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study 80
Response assessment criteria for brain metastases: Proposal from the RANO group 80
Antiangiogenic therapy of brain tumors: The role of bevacizumab 80
Review: Peering through a keyhole: liquid biopsy in primary and metastatic central nervous system tumours 79
The 2021 WHO classification of tumors of the central nervous system: A summary 79
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma. 78
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper. 77
Pathological prognostic markers in central nervous system solitary fibrous tumour/ hemangiopericytoma: Evidence from a small series 75
Current clinical management of elderly patients with glioma 75
On the nature of the so-called monstrocellular sarcoma of the brain. 74
Extent of surgery in low-grade gliomas: an old question in a new context. 74
Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas. 73
Neoplastic meningitis: Clinico-diagnostic aspects [Meningite neoplastica: Aspetti clinico-diagnostici] 73
TRATTAMENTO DELLE METASTASI CEREBRALI 72
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria. 72
Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001. 72
Impiego di temozolomide negli ependimomi intracranici recidivanti dell’adulto 69
ADJUVANT WHOLE BRAIN RADIOTHERAPY VERSUS OBSERVATION AFTER RADIOSURGERY OR SURGICAL RESECTION OF 1-3 CEREBRAL METASTASES-RESULTS OF THE EORTC 22952-26001 STUDY 68
Adverse effects of antiepileptic drugs in brain tumors: Preliminary data of a multi-institutional survey. Are new antiepileptic drugs less toxic? 68
Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group 68
Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments 68
High speed autoradiography on brain tissue sections. 66
Primary lymphomas of the brain: a clinico-pathologic review of 37 cases 66
[Chemotherapy of cerebral tumours: data on malignant gliomas (author's transl)] 66
Neuro-Oncologic Emergencies 65
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. 65
Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016 65
Prognostic value of histologic factors in adult cerebral astrocytoma 63
Caveolin 1 expression independently predicts shorter survival in oligodendrogliomas 63
Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study. 63
Supratotal Resection of Glioblastoma: Is Less More? 62
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma 61
Is there a Role for Bevacizumab in Non-Glial Tumors? 61
NCOG-19. PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH GLIOBLASTOMA: A RETROSPECTIVE INSTITUTIONAL SERIES OF 160 PATIENTS 61
Ependymoma: Evaluation and Management Updates 60
[Long-term results of the treatment of infantile medulloblastoma] 59
Diffusion-Weighted Magnetic Resonance Imaging and ADC Maps in the Diagnosis of Intracranial Cystic or Necrotic Lesions. A retrospective Study on 49 Patients 59
Spinal melanocytoma with leptomeningeal spread and long survival following surgery and chemotherapy 59
Imaging and clinical end points in brain metastases trials. 59
What is New in the Management of Epilepsy in Gliomas? 59
Leptomeningeal metastases: a RANO proposal for response criteria. 59
Proliferating cell nuclear antigen (PCNA) in low-grade astrocytomas: its prognostic significance 58
Paraneoplastic opsoclonus: a neuropathologic study of two cases. 58
[Angiographic vascular images in a case of anaplastic astrocytoma and a case of giant cell sarcoma treated with chemotherapy (proceedings)] 58
[Efficacy of liposomal cytarabine in neoplastic meningitis] 57
Adjuvant Whole Brain Radiotherapy vs. Observation after Radiosurgery or Surgical Resection of 1-3 Cerebral Metastases - Results of the EORTC 22952-26001 Study 57
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO). 57
Histological observations on the regrowth of malignant gliomas after radiotherapy and chemotherapy. 56
Totale 15.791
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.578
article - articoli 0
book - libri 0
conference - conferenze 4.286
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.367 0 0 0 348 177 357 312 235 290 257 227 164
2020/20212.567 204 155 218 167 208 186 257 137 255 243 168 369
2021/20223.157 149 138 194 218 188 214 177 202 149 303 568 657
2022/20233.958 424 238 125 326 307 994 454 223 372 131 206 158
2023/20242.350 294 313 151 158 176 194 154 192 36 149 185 348
2024/2025981 116 446 237 182 0 0 0 0 0 0 0 0
Totale 22.226